Insider transactions

EDGAR

Kezar Life Sciences, Inc.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-22.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
0 transactions, — shares

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–50 of 105

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-05-11 Filed 2026-05-11BERGER FRANKLIN M Director
U

Disposition pursuant to a tender of shares in a change of control transaction

Common Stock
Disposed (D)89,069——0Direct (D) No
F1, F2
  • F1 In connection with the terms of an Agreement and Plan of Merger, dated as of March 30, 2026 (the Merger Agreement), by and among the Issuer, Aurinia Pharma U.S., Inc. (Parent) and Parent's direct wholly owned subsidiary, Aurinia Merger Sub, Inc., (Purchaser), Purchaser completed a tender offer for shares of the Issuer's Common Stock. In exchange for each share, tendering stockholders received: (i) $6.955 per share in cash, without interest and less any applicable tax withholding (the Cash Consideration); plus (ii) one non-tradable contingent value right (each, a CVR), which represents the right to receive certain payments in cash in accordance with the terms and subject to the conditions of a contingent value rights agreement (the CVR Agreement)
  • F2 (continued from footnote 1) without interest and less any applicable tax withholding, upon the achievement of specified milestones in accordance with the terms and subject to the conditions of a CVR Agreement with Broadridge Corporate Issuer Solutions, LLC, as the rights agent. After completion of the tender offer, pursuant to the terms of the Merger Agreement, Purchaser merged with and into the Issuer (the Merger), effective as of May 11, 2026, with the Issuer continuing as the surviving entity and a wholly owned subsidiary of Parent (the Effective Time).
Open filing 0001273885-26-000002 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-11BERGER FRANKLIN M Director
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Stock Option (right to buy) — underlying Common Stock (3,500) — exercise price 26.40
Disposed (D)3,5000—0Direct (D) No
F3
  • F3 Pursuant to the terms of the Merger Agreement, each option to acquire shares of Issuer common stock (the Company Stock Options) that had a per share exercise price equal to or greater than the Cash Amount (an Out-of-the-Money Option), was automatically cancelled and ceased to exist at the Effective Time, and no consideration was delivered in exchange for such Out-of-the-Money Option.
Open filing 0001273885-26-000002 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-11BERGER FRANKLIN M Director
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Stock Option (right to buy) — underlying Common Stock (5,000) — exercise price 6.70
Disposed (D)5,0000—0Direct (D) No
F4
  • F4 Pursuant to the terms of the Merger Agreement, each Company Stock Option that had a per share exercise price less than the Cash Amount (an In-the-Money Option) was automatically cancelled and converted at the Effective Time into the right to receive (A) an amount in cash, without interest, equal to the product obtained by multiplying (x) the excess of the Cash Amount over the exercise price per share underlying such Company Stock Option at the Effective Time by (y) the number of shares underlying such In-the-Money Option, subject to the terms and conditions specified in the Merger Agreement and (B) one CVR in respect of each share underlying such In-the-Money Option.
Open filing 0001273885-26-000002 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-11BERGER FRANKLIN M Director
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Stock Option (right to buy) — underlying Common Stock (5,000) — exercise price 4.46
Disposed (D)5,0000—0Direct (D) No
F4
  • F4 Pursuant to the terms of the Merger Agreement, each Company Stock Option that had a per share exercise price less than the Cash Amount (an In-the-Money Option) was automatically cancelled and converted at the Effective Time into the right to receive (A) an amount in cash, without interest, equal to the product obtained by multiplying (x) the excess of the Cash Amount over the exercise price per share underlying such Company Stock Option at the Effective Time by (y) the number of shares underlying such In-the-Money Option, subject to the terms and conditions specified in the Merger Agreement and (B) one CVR in respect of each share underlying such In-the-Money Option.
Open filing 0001273885-26-000002 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-11BERGER FRANKLIN M Director
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Stock Option (right to buy) — underlying Common Stock (2,600) — exercise price 22.80
Disposed (D)2,6000—0Direct (D) No
F3
  • F3 Pursuant to the terms of the Merger Agreement, each option to acquire shares of Issuer common stock (the Company Stock Options) that had a per share exercise price equal to or greater than the Cash Amount (an Out-of-the-Money Option), was automatically cancelled and ceased to exist at the Effective Time, and no consideration was delivered in exchange for such Out-of-the-Money Option.
Open filing 0001273885-26-000002 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-11BERGER FRANKLIN M Director
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Stock Option (right to buy) — underlying Common Stock (2,600) — exercise price 22.80
Disposed (D)2,6000—0Direct (D) No
F3
  • F3 Pursuant to the terms of the Merger Agreement, each option to acquire shares of Issuer common stock (the Company Stock Options) that had a per share exercise price equal to or greater than the Cash Amount (an Out-of-the-Money Option), was automatically cancelled and ceased to exist at the Effective Time, and no consideration was delivered in exchange for such Out-of-the-Money Option.
Open filing 0001273885-26-000002 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-11Klearman Micki Director
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Stock Option (right to buy) — underlying Common Stock (3,500) — exercise price 26.40
Disposed (D)3,5000—0Direct (D) No
F1
  • F1 Pursuant to the terms of the Agreement and Plan of Merger, dated as of March 30, 2026 (the Merger Agreement), each option to acquire shares of Issuer common stock (the Company Stock Options) that had a per share exercise price equal to or greater than $6.955 per share (Cash Amount) (an Out-of-the-Money Option), was automatically cancelled and ceased to exist after completion of the tender offer, pursuant to the terms of the Merger Agreement, Purchaser merged with and into the Issuer (the Merger), effective as of May 11, 2026, with the Issuer continuing as the surviving entity and a wholly owned subsidiary of Parent (the Effective Time) , and no consideration was delivered in exchange for such Out-of-the-Money Option.
Open filing 0001864934-26-000002 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-11Klearman Micki Director
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Stock Option (right to buy) — underlying Common Stock (5,000) — exercise price 6.70
Disposed (D)5,0000—0Direct (D) No
F2
  • F2 Pursuant to the terms of the Merger Agreement, each Company Stock Option that had a per share exercise price less than the Cash Amount (an In-the-Money Option) was automatically cancelled and converted at the Effective Time into the right to receive (A) an amount in cash, without interest, equal to the product obtained by multiplying (x) the excess of the Cash Amount over the exercise price per share underlying such Company Stock Option at the Effective Time by (y) the number of shares underlying such In-the-Money Option, subject to the terms and conditions specified in the Merger Agreement and (B) one CVR in respect of each share underlying such In-the-Money Option.
Open filing 0001864934-26-000002 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-11Klearman Micki Director
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Stock Option (right to buy) — underlying Common Stock (5,000) — exercise price 4.46
Disposed (D)5,0000—0Direct (D) No
F2
  • F2 Pursuant to the terms of the Merger Agreement, each Company Stock Option that had a per share exercise price less than the Cash Amount (an In-the-Money Option) was automatically cancelled and converted at the Effective Time into the right to receive (A) an amount in cash, without interest, equal to the product obtained by multiplying (x) the excess of the Cash Amount over the exercise price per share underlying such Company Stock Option at the Effective Time by (y) the number of shares underlying such In-the-Money Option, subject to the terms and conditions specified in the Merger Agreement and (B) one CVR in respect of each share underlying such In-the-Money Option.
Open filing 0001864934-26-000002 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-11Klearman Micki Director
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Stock Option (right to buy) — underlying Common Stock (5,200) — exercise price 22.80
Disposed (D)5,2000—0Direct (D) No
F1
  • F1 Pursuant to the terms of the Agreement and Plan of Merger, dated as of March 30, 2026 (the Merger Agreement), each option to acquire shares of Issuer common stock (the Company Stock Options) that had a per share exercise price equal to or greater than $6.955 per share (Cash Amount) (an Out-of-the-Money Option), was automatically cancelled and ceased to exist after completion of the tender offer, pursuant to the terms of the Merger Agreement, Purchaser merged with and into the Issuer (the Merger), effective as of May 11, 2026, with the Issuer continuing as the surviving entity and a wholly owned subsidiary of Parent (the Effective Time) , and no consideration was delivered in exchange for such Out-of-the-Money Option.
Open filing 0001864934-26-000002 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-11Klearman Micki Director
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Stock Option (right to buy) — underlying Common Stock (2,600) — exercise price 22.80
Disposed (D)2,6000—0Direct (D) No
F1
  • F1 Pursuant to the terms of the Agreement and Plan of Merger, dated as of March 30, 2026 (the Merger Agreement), each option to acquire shares of Issuer common stock (the Company Stock Options) that had a per share exercise price equal to or greater than $6.955 per share (Cash Amount) (an Out-of-the-Money Option), was automatically cancelled and ceased to exist after completion of the tender offer, pursuant to the terms of the Merger Agreement, Purchaser merged with and into the Issuer (the Merger), effective as of May 11, 2026, with the Issuer continuing as the surviving entity and a wholly owned subsidiary of Parent (the Effective Time) , and no consideration was delivered in exchange for such Out-of-the-Money Option.
Open filing 0001864934-26-000002 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-11Klearman Micki Director
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Stock Option (right to buy) — underlying Common Stock (2,600) — exercise price 22.80
Disposed (D)2,6000—0Direct (D) No
F1
  • F1 Pursuant to the terms of the Agreement and Plan of Merger, dated as of March 30, 2026 (the Merger Agreement), each option to acquire shares of Issuer common stock (the Company Stock Options) that had a per share exercise price equal to or greater than $6.955 per share (Cash Amount) (an Out-of-the-Money Option), was automatically cancelled and ceased to exist after completion of the tender offer, pursuant to the terms of the Merger Agreement, Purchaser merged with and into the Issuer (the Merger), effective as of May 11, 2026, with the Issuer continuing as the surviving entity and a wholly owned subsidiary of Parent (the Effective Time) , and no consideration was delivered in exchange for such Out-of-the-Money Option.
Open filing 0001864934-26-000002 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-11Garner Elizabeth Director
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Stock Option (right to buy) — underlying Common Stock (3,500) — exercise price 26.40
Disposed (D)3,5000—0Direct (D) No
F1
  • F1 Pursuant to the terms of the Agreement and Plan of Merger, dated as of March 30, 2026 (the Merger Agreement), each option to acquire shares of Issuer common stock (the Company Stock Options) that had a per share exercise price equal to or greater than $6.955 per share (Cash Amount) (an Out-of-the-Money Option), was automatically cancelled and ceased to exist after completion of the tender offer, pursuant to the terms of the Merger Agreement, Purchaser merged with and into the Issuer (the Merger), effective as of May 11, 2026, with the Issuer continuing as the surviving entity and a wholly owned subsidiary of Parent (the Effective Time) , and no consideration was delivered in exchange for such Out-of-the-Money Option.
Open filing 0001608578-26-000002 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-11Garner Elizabeth Director
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Stock Option (right to buy) — underlying Common Stock (5,000) — exercise price 6.70
Disposed (D)5,0000—0Direct (D) No
F2
  • F2 Pursuant to the terms of the Merger Agreement, each Company Stock Option that had a per share exercise price less than the Cash Amount (an In-the-Money Option) was automatically cancelled and converted at the Effective Time into the right to receive (A) an amount in cash, without interest, equal to the product obtained by multiplying (x) the excess of the Cash Amount over the exercise price per share underlying such Company Stock Option at the Effective Time by (y) the number of shares underlying such In-the-Money Option, subject to the terms and conditions specified in the Merger Agreement and (B) one CVR in respect of each share underlying such In-the-Money Option.
Open filing 0001608578-26-000002 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-11Garner Elizabeth Director
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Stock Option (right to buy) — underlying Common Stock (5,000) — exercise price 4.46
Disposed (D)5,0000—0Direct (D) No
F2
  • F2 Pursuant to the terms of the Merger Agreement, each Company Stock Option that had a per share exercise price less than the Cash Amount (an In-the-Money Option) was automatically cancelled and converted at the Effective Time into the right to receive (A) an amount in cash, without interest, equal to the product obtained by multiplying (x) the excess of the Cash Amount over the exercise price per share underlying such Company Stock Option at the Effective Time by (y) the number of shares underlying such In-the-Money Option, subject to the terms and conditions specified in the Merger Agreement and (B) one CVR in respect of each share underlying such In-the-Money Option.
Open filing 0001608578-26-000002 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-11Garner Elizabeth Director
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Stock Option (right to buy) — underlying Common Stock (1,779) — exercise price 22.80
Disposed (D)1,7790—0Direct (D) No
F1
  • F1 Pursuant to the terms of the Agreement and Plan of Merger, dated as of March 30, 2026 (the Merger Agreement), each option to acquire shares of Issuer common stock (the Company Stock Options) that had a per share exercise price equal to or greater than $6.955 per share (Cash Amount) (an Out-of-the-Money Option), was automatically cancelled and ceased to exist after completion of the tender offer, pursuant to the terms of the Merger Agreement, Purchaser merged with and into the Issuer (the Merger), effective as of May 11, 2026, with the Issuer continuing as the surviving entity and a wholly owned subsidiary of Parent (the Effective Time) , and no consideration was delivered in exchange for such Out-of-the-Money Option.
Open filing 0001608578-26-000002 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-11Garner Elizabeth Director
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Stock Option (right to buy) — underlying Common Stock (889) — exercise price 22.80
Disposed (D)8890—0Direct (D) No
F1
  • F1 Pursuant to the terms of the Agreement and Plan of Merger, dated as of March 30, 2026 (the Merger Agreement), each option to acquire shares of Issuer common stock (the Company Stock Options) that had a per share exercise price equal to or greater than $6.955 per share (Cash Amount) (an Out-of-the-Money Option), was automatically cancelled and ceased to exist after completion of the tender offer, pursuant to the terms of the Merger Agreement, Purchaser merged with and into the Issuer (the Merger), effective as of May 11, 2026, with the Issuer continuing as the surviving entity and a wholly owned subsidiary of Parent (the Effective Time) , and no consideration was delivered in exchange for such Out-of-the-Money Option.
Open filing 0001608578-26-000002 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-11Garner Elizabeth Director
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Stock Option (right to buy) — underlying Common Stock (2,600) — exercise price 22.80
Disposed (D)2,6000—0Direct (D) No
F1
  • F1 Pursuant to the terms of the Agreement and Plan of Merger, dated as of March 30, 2026 (the Merger Agreement), each option to acquire shares of Issuer common stock (the Company Stock Options) that had a per share exercise price equal to or greater than $6.955 per share (Cash Amount) (an Out-of-the-Money Option), was automatically cancelled and ceased to exist after completion of the tender offer, pursuant to the terms of the Merger Agreement, Purchaser merged with and into the Issuer (the Merger), effective as of May 11, 2026, with the Issuer continuing as the surviving entity and a wholly owned subsidiary of Parent (the Effective Time) , and no consideration was delivered in exchange for such Out-of-the-Money Option.
Open filing 0001608578-26-000002 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-11Garner Elizabeth Director
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Stock Option (right to buy) — underlying Common Stock (2,600) — exercise price 22.80
Disposed (D)2,6000—0Direct (D) No
F1
  • F1 Pursuant to the terms of the Agreement and Plan of Merger, dated as of March 30, 2026 (the Merger Agreement), each option to acquire shares of Issuer common stock (the Company Stock Options) that had a per share exercise price equal to or greater than $6.955 per share (Cash Amount) (an Out-of-the-Money Option), was automatically cancelled and ceased to exist after completion of the tender offer, pursuant to the terms of the Merger Agreement, Purchaser merged with and into the Issuer (the Merger), effective as of May 11, 2026, with the Issuer continuing as the surviving entity and a wholly owned subsidiary of Parent (the Effective Time) , and no consideration was delivered in exchange for such Out-of-the-Money Option.
Open filing 0001608578-26-000002 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-11Kirk Christopher J. Director · Officer: CEO
U

Disposition pursuant to a tender of shares in a change of control transaction

Common Stock
Disposed (D)43,134——0Direct (D) No
F1, F2
  • F1 In connection with the terms of an Agreement and Plan of Merger, dated as of March 30, 2026 (the Merger Agreement), by and among the Issuer, Aurinia Pharma U.S., Inc. (Parent) and Parent's direct wholly owned subsidiary, Aurinia Merger Sub, Inc., (Purchaser), Purchaser completed a tender offer for shares of the Issuer's Common Stock. In exchange for each share, tendering stockholders received: (i) $6.955 per share in cash, without interest and less any applicable tax withholding (the Cash Consideration); plus (ii) one non-tradable contingent value right (each, a CVR), which represents the right to receive certain payments in cash in accordance with the terms and subject to the conditions of a contingent value rights agreement (the CVR Agreement)
  • F2 (continued from footnote 1) without interest and less any applicable tax withholding, upon the achievement of specified milestones in accordance with the terms and subject to the conditions of a CVR Agreement with Broadridge Corporate Issuer Solutions, LLC, as the rights agent. After completion of the tender offer, pursuant to the terms of the Merger Agreement, Purchaser merged with and into the Issuer (the Merger), effective as of May 11, 2026, with the Issuer continuing as the surviving entity and a wholly owned subsidiary of Parent (the Effective Time).
Open filing 0001744253-26-000002 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-11Kirk Christopher J. Director · Officer: CEO
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Employee Stock Option (right to buy) — underlying Common Stock (4,448) — exercise price 14.10
Disposed (D)4,4480—0Direct (D) No
F3
  • F3 Pursuant to the terms of the Merger Agreement, each option to acquire shares of Issuer common stock (the Company Stock Options) that had a per share exercise price equal to or greater than the Cash Amount (an Out-of-the-Money Option), was automatically cancelled and ceased to exist at the Effective Time, and no consideration was delivered in exchange for such Out-of-the-Money Option.
Open filing 0001744253-26-000002 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-11Kirk Christopher J. Director · Officer: CEO
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Employee Stock Option (right to buy) — underlying Common Stock (17,792) — exercise price 23.70
Disposed (D)17,7920—0Direct (D) No
F3
  • F3 Pursuant to the terms of the Merger Agreement, each option to acquire shares of Issuer common stock (the Company Stock Options) that had a per share exercise price equal to or greater than the Cash Amount (an Out-of-the-Money Option), was automatically cancelled and ceased to exist at the Effective Time, and no consideration was delivered in exchange for such Out-of-the-Money Option.
Open filing 0001744253-26-000002 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-11Kirk Christopher J. Director · Officer: CEO
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Employee Stock Option (right to buy) — underlying Common Stock (8,896) — exercise price 23.70
Disposed (D)8,8960—0Direct (D) No
F3
  • F3 Pursuant to the terms of the Merger Agreement, each option to acquire shares of Issuer common stock (the Company Stock Options) that had a per share exercise price equal to or greater than the Cash Amount (an Out-of-the-Money Option), was automatically cancelled and ceased to exist at the Effective Time, and no consideration was delivered in exchange for such Out-of-the-Money Option.
Open filing 0001744253-26-000002 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-11Kirk Christopher J. Director · Officer: CEO
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Employee Stock Option (right to buy) — underlying Common Stock (7,117) — exercise price 59.10
Disposed (D)7,1170—0Direct (D) No
F3
  • F3 Pursuant to the terms of the Merger Agreement, each option to acquire shares of Issuer common stock (the Company Stock Options) that had a per share exercise price equal to or greater than the Cash Amount (an Out-of-the-Money Option), was automatically cancelled and ceased to exist at the Effective Time, and no consideration was delivered in exchange for such Out-of-the-Money Option.
Open filing 0001744253-26-000002 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-11Kirk Christopher J. Director · Officer: CEO
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Employee Stock Option (right to buy) — underlying Common Stock (87,499) — exercise price 8.40
Disposed (D)87,4990—0Direct (D) No
F3
  • F3 Pursuant to the terms of the Merger Agreement, each option to acquire shares of Issuer common stock (the Company Stock Options) that had a per share exercise price equal to or greater than the Cash Amount (an Out-of-the-Money Option), was automatically cancelled and ceased to exist at the Effective Time, and no consideration was delivered in exchange for such Out-of-the-Money Option.
Open filing 0001744253-26-000002 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-11Kirk Christopher J. Director · Officer: CEO
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Employee Stock Option (right to buy) — underlying Common Stock (120,000) — exercise price 6.58
Disposed (D)120,0000—0Direct (D) No
F4
  • F4 Pursuant to the terms of the Merger Agreement, each Company Stock Option that had a per share exercise price less than the Cash Amount (an In-the-Money Option) was automatically cancelled and converted at the Effective Time into the right to receive (A) an amount in cash, without interest, equal to the product obtained by multiplying (x) the excess of the Cash Amount over the exercise price per share underlying such Company Stock Option at the Effective Time by (y) the number of shares underlying such In-the-Money Option, subject to the terms and conditions specified in the Merger Agreement and (B) one CVR in respect of each share underlying such In-the-Money Option.
Open filing 0001744253-26-000002 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-11Kirk Christopher J. Director · Officer: CEO
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Employee Stock Option (right to buy) — underlying Common Stock (8,749) — exercise price 22.80
Disposed (D)8,7490—0Direct (D) No
F3
  • F3 Pursuant to the terms of the Merger Agreement, each option to acquire shares of Issuer common stock (the Company Stock Options) that had a per share exercise price equal to or greater than the Cash Amount (an Out-of-the-Money Option), was automatically cancelled and ceased to exist at the Effective Time, and no consideration was delivered in exchange for such Out-of-the-Money Option.
Open filing 0001744253-26-000002 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-11Kirk Christopher J. Director · Officer: CEO
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Employee Stock Option (right to buy) — underlying Common Stock (12,499) — exercise price 22.80
Disposed (D)12,4990—0Direct (D) No
F3
  • F3 Pursuant to the terms of the Merger Agreement, each option to acquire shares of Issuer common stock (the Company Stock Options) that had a per share exercise price equal to or greater than the Cash Amount (an Out-of-the-Money Option), was automatically cancelled and ceased to exist at the Effective Time, and no consideration was delivered in exchange for such Out-of-the-Money Option.
Open filing 0001744253-26-000002 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-11Kirk Christopher J. Director · Officer: CEO
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Employee Stock Option (right to buy) — underlying Common Stock (25,999) — exercise price 22.80
Disposed (D)25,9990—0Direct (D) No
F3
  • F3 Pursuant to the terms of the Merger Agreement, each option to acquire shares of Issuer common stock (the Company Stock Options) that had a per share exercise price equal to or greater than the Cash Amount (an Out-of-the-Money Option), was automatically cancelled and ceased to exist at the Effective Time, and no consideration was delivered in exchange for such Out-of-the-Money Option.
Open filing 0001744253-26-000002 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-11Kirk Christopher J. Director · Officer: CEO
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Employee Stock Option (right to buy) — underlying Common Stock (16,999) — exercise price 22.80
Disposed (D)16,9990—0Direct (D) No
F3
  • F3 Pursuant to the terms of the Merger Agreement, each option to acquire shares of Issuer common stock (the Company Stock Options) that had a per share exercise price equal to or greater than the Cash Amount (an Out-of-the-Money Option), was automatically cancelled and ceased to exist at the Effective Time, and no consideration was delivered in exchange for such Out-of-the-Money Option.
Open filing 0001744253-26-000002 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-11Kirk Christopher J. Director · Officer: CEO
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Employee Stock Option (right to buy) — underlying Common Stock (18,999) — exercise price 22.80
Disposed (D)18,9990—0Direct (D) No
F3
  • F3 Pursuant to the terms of the Merger Agreement, each option to acquire shares of Issuer common stock (the Company Stock Options) that had a per share exercise price equal to or greater than the Cash Amount (an Out-of-the-Money Option), was automatically cancelled and ceased to exist at the Effective Time, and no consideration was delivered in exchange for such Out-of-the-Money Option.
Open filing 0001744253-26-000002 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-11Chiang Pichi Luo Officer: SVP, Corporate Controller
U

Disposition pursuant to a tender of shares in a change of control transaction

Common Stock
Disposed (D)2,711——0Direct (D) No
F1, F2
  • F1 In connection with the terms of an Agreement and Plan of Merger, dated as of March 30, 2026 (the Merger Agreement), by and among the Issuer, Aurinia Pharma U.S., Inc. (Parent) and Parent's direct wholly owned subsidiary, Aurinia Merger Sub, Inc., (Purchaser), Purchaser completed a tender offer for shares of the Issuer's Common Stock. In exchange for each share, tendering stockholders received: (i) $6.955 per share in cash, without interest and less any applicable tax withholding (the Cash Consideration); plus (ii) one non-tradable contingent value right (each, a CVR), which represents the right to receive certain payments in cash in accordance with the terms and subject to the conditions of a contingent value rights agreement (the CVR Agreement)
  • F2 (continued from footnote 1) without interest and less any applicable tax withholding, upon the achievement of specified milestones in accordance with the terms and subject to the conditions of a CVR Agreement with Broadridge Corporate Issuer Solutions, LLC, as the rights agent. After completion of the tender offer, pursuant to the terms of the Merger Agreement, Purchaser merged with and into the Issuer (the Merger), effective as of May 11, 2026, with the Issuer continuing as the surviving entity and a wholly owned subsidiary of Parent (the Effective Time).
Open filing 0002064744-26-000002 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-11Chiang Pichi Luo Officer: SVP, Corporate Controller
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Employee Stock Option (right to buy) — underlying Common Stock (10,000) — exercise price 9.30
Disposed (D)10,0000—0Direct (D) No
F3
  • F3 Pursuant to the terms of the Merger Agreement, each option to acquire shares of Issuer common stock (the Company Stock Options) that had a per share exercise price equal to or greater than the Cash Amount (an Out-of-the-Money Option), was automatically cancelled and ceased to exist at the Effective Time, and no consideration was delivered in exchange for such Out-of-the-Money Option.
Open filing 0002064744-26-000002 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-11Chiang Pichi Luo Officer: SVP, Corporate Controller
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Employee Stock Option (right to buy) — underlying Common Stock (12,500) — exercise price 6.30
Disposed (D)12,5000—0Direct (D) No
F4
  • F4 Pursuant to the terms of the Merger Agreement, each Company Stock Option that had a per share exercise price less than the Cash Amount (an In-the-Money Option) was automatically cancelled and converted at the Effective Time into the right to receive (A) an amount in cash, without interest, equal to the product obtained by multiplying (x) the excess of the Cash Amount over the exercise price per share underlying such Company Stock Option at the Effective Time by (y) the number of shares underlying such In-the-Money Option, subject to the terms and conditions specified in the Merger Agreement and (B) one CVR in respect of each share underlying such In-the-Money Option.
Open filing 0002064744-26-000002 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-11Chiang Pichi Luo Officer: SVP, Corporate Controller
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Employee Stock Option (right to buy) — underlying Common Stock (17,500) — exercise price 6.58
Disposed (D)17,5000—0Direct (D) No
F4
  • F4 Pursuant to the terms of the Merger Agreement, each Company Stock Option that had a per share exercise price less than the Cash Amount (an In-the-Money Option) was automatically cancelled and converted at the Effective Time into the right to receive (A) an amount in cash, without interest, equal to the product obtained by multiplying (x) the excess of the Cash Amount over the exercise price per share underlying such Company Stock Option at the Effective Time by (y) the number of shares underlying such In-the-Money Option, subject to the terms and conditions specified in the Merger Agreement and (B) one CVR in respect of each share underlying such In-the-Money Option.
Open filing 0002064744-26-000002 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-11Chiang Pichi Luo Officer: SVP, Corporate Controller
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Employee Stock Option (right to buy) — underlying Common Stock (7,500) — exercise price 6.30
Disposed (D)7,5000—0Direct (D) No
F4
  • F4 Pursuant to the terms of the Merger Agreement, each Company Stock Option that had a per share exercise price less than the Cash Amount (an In-the-Money Option) was automatically cancelled and converted at the Effective Time into the right to receive (A) an amount in cash, without interest, equal to the product obtained by multiplying (x) the excess of the Cash Amount over the exercise price per share underlying such Company Stock Option at the Effective Time by (y) the number of shares underlying such In-the-Money Option, subject to the terms and conditions specified in the Merger Agreement and (B) one CVR in respect of each share underlying such In-the-Money Option.
Open filing 0002064744-26-000002 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-11Chiang Pichi Luo Officer: SVP, Corporate Controller
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Employee Stock Option (right to buy) — underlying Common Stock (1,199) — exercise price 22.80
Disposed (D)1,1990—0Direct (D) No
F3
  • F3 Pursuant to the terms of the Merger Agreement, each option to acquire shares of Issuer common stock (the Company Stock Options) that had a per share exercise price equal to or greater than the Cash Amount (an Out-of-the-Money Option), was automatically cancelled and ceased to exist at the Effective Time, and no consideration was delivered in exchange for such Out-of-the-Money Option.
Open filing 0002064744-26-000002 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-11Chiang Pichi Luo Officer: SVP, Corporate Controller
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Employee Stock Option (right to buy) — underlying Common Stock (2,052) — exercise price 22.80
Disposed (D)2,0520—0Direct (D) No
F3
  • F3 Pursuant to the terms of the Merger Agreement, each option to acquire shares of Issuer common stock (the Company Stock Options) that had a per share exercise price equal to or greater than the Cash Amount (an Out-of-the-Money Option), was automatically cancelled and ceased to exist at the Effective Time, and no consideration was delivered in exchange for such Out-of-the-Money Option.
Open filing 0002064744-26-000002 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-11Chiang Pichi Luo Officer: SVP, Corporate Controller
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Employee Stock Option (right to buy) — underlying Common Stock (599) — exercise price 22.80
Disposed (D)5990—0Direct (D) No
F3
  • F3 Pursuant to the terms of the Merger Agreement, each option to acquire shares of Issuer common stock (the Company Stock Options) that had a per share exercise price equal to or greater than the Cash Amount (an Out-of-the-Money Option), was automatically cancelled and ceased to exist at the Effective Time, and no consideration was delivered in exchange for such Out-of-the-Money Option.
Open filing 0002064744-26-000002 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-11Chiang Pichi Luo Officer: SVP, Corporate Controller
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Employee Stock Option (right to buy) — underlying Common Stock (2,401) — exercise price 22.80
Disposed (D)2,4010—0Direct (D) No
F3
  • F3 Pursuant to the terms of the Merger Agreement, each option to acquire shares of Issuer common stock (the Company Stock Options) that had a per share exercise price equal to or greater than the Cash Amount (an Out-of-the-Money Option), was automatically cancelled and ceased to exist at the Effective Time, and no consideration was delivered in exchange for such Out-of-the-Money Option.
Open filing 0002064744-26-000002 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-11Chiang Pichi Luo Officer: SVP, Corporate Controller
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Employee Stock Option (right to buy) — underlying Common Stock (2,499) — exercise price 22.80
Disposed (D)2,4990—0Direct (D) No
F3
  • F3 Pursuant to the terms of the Merger Agreement, each option to acquire shares of Issuer common stock (the Company Stock Options) that had a per share exercise price equal to or greater than the Cash Amount (an Out-of-the-Money Option), was automatically cancelled and ceased to exist at the Effective Time, and no consideration was delivered in exchange for such Out-of-the-Money Option.
Open filing 0002064744-26-000002 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-11Chiang Pichi Luo Officer: SVP, Corporate Controller
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Employee Stock Option (right to buy) — underlying Common Stock (2,899) — exercise price 22.80
Disposed (D)2,8990—0Direct (D) No
F3
  • F3 Pursuant to the terms of the Merger Agreement, each option to acquire shares of Issuer common stock (the Company Stock Options) that had a per share exercise price equal to or greater than the Cash Amount (an Out-of-the-Money Option), was automatically cancelled and ceased to exist at the Effective Time, and no consideration was delivered in exchange for such Out-of-the-Money Option.
Open filing 0002064744-26-000002 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-11Chiang Pichi Luo Officer: SVP, Corporate Controller
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Employee Stock Option (right to buy) — underlying Common Stock (2,899) — exercise price 22.80
Disposed (D)2,8990—0Direct (D) No
F3
  • F3 Pursuant to the terms of the Merger Agreement, each option to acquire shares of Issuer common stock (the Company Stock Options) that had a per share exercise price equal to or greater than the Cash Amount (an Out-of-the-Money Option), was automatically cancelled and ceased to exist at the Effective Time, and no consideration was delivered in exchange for such Out-of-the-Money Option.
Open filing 0002064744-26-000002 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-11Chiang Pichi Luo Officer: SVP, Corporate Controller
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Employee Stock Option (right to buy) — underlying Common Stock (4,999) — exercise price 22.80
Disposed (D)4,9990—0Direct (D) No
F3
  • F3 Pursuant to the terms of the Merger Agreement, each option to acquire shares of Issuer common stock (the Company Stock Options) that had a per share exercise price equal to or greater than the Cash Amount (an Out-of-the-Money Option), was automatically cancelled and ceased to exist at the Effective Time, and no consideration was delivered in exchange for such Out-of-the-Money Option.
Open filing 0002064744-26-000002 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-11Chiang Pichi Luo Officer: SVP, Corporate Controller
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Employee Stock Option (right to buy) — underlying Common Stock (7,999) — exercise price 22.80
Disposed (D)7,9990—0Direct (D) No
F3
  • F3 Pursuant to the terms of the Merger Agreement, each option to acquire shares of Issuer common stock (the Company Stock Options) that had a per share exercise price equal to or greater than the Cash Amount (an Out-of-the-Money Option), was automatically cancelled and ceased to exist at the Effective Time, and no consideration was delivered in exchange for such Out-of-the-Money Option.
Open filing 0002064744-26-000002 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-11Belsky Marc Officer: Chief Financial Officer
U

Disposition pursuant to a tender of shares in a change of control transaction

Common Stock
Disposed (D)1,538——0Direct (D) No
F1, F2
  • F1 In connection with the terms of an Agreement and Plan of Merger, dated as of March 30, 2026 (the Merger Agreement), by and among the Issuer, Aurinia Pharma U.S., Inc. (Parent) and Parent's direct wholly owned subsidiary, Aurinia Merger Sub, Inc., (Purchaser), Purchaser completed a tender offer for shares of the Issuer's Common Stock. In exchange for each share, tendering stockholders received: (i) $6.955 per share in cash, without interest and less any applicable tax withholding (the Cash Consideration); plus (ii) one non-tradable contingent value right (each, a CVR), which represents the right to receive certain payments in cash in accordance with the terms and subject to the conditions of a contingent value rights agreement (the CVR Agreement)
  • F2 (continued from footnote 1) without interest and less any applicable tax withholding, upon the achievement of specified milestones in accordance with the terms and subject to the conditions of a CVR Agreement with Broadridge Corporate Issuer Solutions, LLC, as the rights agent. After completion of the tender offer, pursuant to the terms of the Merger Agreement, Purchaser merged with and into the Issuer (the Merger), effective as of May 11, 2026, with the Issuer continuing as the surviving entity and a wholly owned subsidiary of Parent (the Effective Time).
Open filing 0001382629-26-000003 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-11Belsky Marc Officer: Chief Financial Officer
U

Disposition pursuant to a tender of shares in a change of control transaction

Common Stock
Disposed (D)200——0Indirect (I) By TrustNo
F1, F2
  • F1 In connection with the terms of an Agreement and Plan of Merger, dated as of March 30, 2026 (the Merger Agreement), by and among the Issuer, Aurinia Pharma U.S., Inc. (Parent) and Parent's direct wholly owned subsidiary, Aurinia Merger Sub, Inc., (Purchaser), Purchaser completed a tender offer for shares of the Issuer's Common Stock. In exchange for each share, tendering stockholders received: (i) $6.955 per share in cash, without interest and less any applicable tax withholding (the Cash Consideration); plus (ii) one non-tradable contingent value right (each, a CVR), which represents the right to receive certain payments in cash in accordance with the terms and subject to the conditions of a contingent value rights agreement (the CVR Agreement)
  • F2 (continued from footnote 1) without interest and less any applicable tax withholding, upon the achievement of specified milestones in accordance with the terms and subject to the conditions of a CVR Agreement with Broadridge Corporate Issuer Solutions, LLC, as the rights agent. After completion of the tender offer, pursuant to the terms of the Merger Agreement, Purchaser merged with and into the Issuer (the Merger), effective as of May 11, 2026, with the Issuer continuing as the surviving entity and a wholly owned subsidiary of Parent (the Effective Time).
Open filing 0001382629-26-000003 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-11Belsky Marc Officer: Chief Financial Officer
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Employee Stock Option (right to buy) — underlying Common Stock (17,793) — exercise price 59.10
Disposed (D)17,7930—0Direct (D) No
F3
  • F3 Pursuant to the terms of the Merger Agreement, each option to acquire shares of Issuer common stock (the Company Stock Options) that had a per share exercise price equal to or greater than the Cash Amount (an Out-of-the-Money Option), was automatically cancelled and ceased to exist at the Effective Time, and no consideration was delivered in exchange for such Out-of-the-Money Option.
Open filing 0001382629-26-000003 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-11Belsky Marc Officer: Chief Financial Officer
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Employee Stock Option (right to buy) — underlying Common Stock (29,499) — exercise price 9.30
Disposed (D)29,4990—0Direct (D) No
F3
  • F3 Pursuant to the terms of the Merger Agreement, each option to acquire shares of Issuer common stock (the Company Stock Options) that had a per share exercise price equal to or greater than the Cash Amount (an Out-of-the-Money Option), was automatically cancelled and ceased to exist at the Effective Time, and no consideration was delivered in exchange for such Out-of-the-Money Option.
Open filing 0001382629-26-000003 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-11Belsky Marc Officer: Chief Financial Officer
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Derivative security: Employee Stock Option (right to buy) — underlying Common Stock (24,500) — exercise price 6.58
Disposed (D)24,5000—0Direct (D) No
F4
  • F4 Pursuant to the terms of the Merger Agreement, each Company Stock Option that had a per share exercise price less than the Cash Amount (an In-the-Money Option) was automatically cancelled and converted at the Effective Time into the right to receive (A) an amount in cash, without interest, equal to the product obtained by multiplying (x) the excess of the Cash Amount over the exercise price per share underlying such Company Stock Option at the Effective Time by (y) the number of shares underlying such In-the-Money Option, subject to the terms and conditions specified in the Merger Agreement and (B) one CVR in respect of each share underlying such In-the-Money Option.
Open filing 0001382629-26-000003 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

No Form 13F position in this issuer is placed in the store. A holder not yet linked or not yet filed is absent, not zero.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
Baselake Partners, LP Common Stock, $0.001 par value per share0005/11/2026 Filed 2026-05-28SCHEDULE 13G/AAmendment 2Open filing 0001957912-26-000022 Dispute this row
Baselake Management, LLC Common Stock, $0.001 par value per share0005/11/2026 Filed 2026-05-28SCHEDULE 13G/AAmendment 2Open filing 0001957912-26-000022 Dispute this row
David Paolella Common Stock, $0.001 par value per share0005/11/2026 Filed 2026-05-28SCHEDULE 13G/AAmendment 2Open filing 0001957912-26-000022 Dispute this row
TANG CAPITAL MANAGEMENT, LLC Common Stock, par value $0.001 per share00.0005/11/2026 Filed 2026-05-13SCHEDULE 13D/AAmendment 2Open filing 0001214659-26-006096 Dispute this row
KEVIN TANG Common Stock, par value $0.001 per share00.0005/11/2026 Filed 2026-05-13SCHEDULE 13D/AAmendment 2Open filing 0001214659-26-006096 Dispute this row
TANG CAPITAL PARTNERS, LP Common Stock, par value $0.001 per share00.0005/11/2026 Filed 2026-05-13SCHEDULE 13D/AAmendment 2Open filing 0001214659-26-006096 Dispute this row
TANG CAPITAL PARTNERS INTERNATIONAL, LP Common Stock, par value $0.001 per share00.0005/11/2026 Filed 2026-05-13SCHEDULE 13D/AAmendment 2Open filing 0001214659-26-006096 Dispute this row
TANG CAPITAL PARTNERS III, INC Common Stock, par value $0.001 per share00.0005/11/2026 Filed 2026-05-13SCHEDULE 13D/AAmendment 2Open filing 0001214659-26-006096 Dispute this row
TANG CAPITAL PARTNERS IV, INC Common Stock, par value $0.001 per share00.0005/11/2026 Filed 2026-05-13SCHEDULE 13D/AAmendment 2Open filing 0001214659-26-006096 Dispute this row
CONCENTRA BIOSCIENCES, LLC Common Stock, par value $0.001 per share00.0005/11/2026 Filed 2026-05-13SCHEDULE 13D/AAmendment 2Open filing 0001214659-26-006096 Dispute this row
Baselake Partners, LP Common Stock, $0.001 par value per share0005/11/2026 Filed 2026-05-12SCHEDULE 13G/AAmendment 1Open filing 0001957912-26-000020 Dispute this row
Baselake Management, LLC Common Stock, $0.001 par value per share0005/11/2026 Filed 2026-05-12SCHEDULE 13G/AAmendment 1Open filing 0001957912-26-000020 Dispute this row
David Paolella Common Stock, $0.001 par value per share0391,86205/11/2026 Filed 2026-05-12SCHEDULE 13G/AAmendment 1Open filing 0001957912-26-000020 Dispute this row
BML Investment Partners, L.P. Common Stock, $0.001 par value0005/11/2026 Filed 2026-05-12SCHEDULE 13G/AAmendment 3Open filing 0001373604-26-000039 Dispute this row
Baselake Partners, LP Common Stock, $0.001 par value per share5.3391,862.0003/30/2026 Filed 2026-04-06SCHEDULE 13GOpen filing 0001493152-26-015369 Dispute this row
Baselake Management, LLC Common Stock, $0.001 par value per share5.3391,862.0003/30/2026 Filed 2026-04-06SCHEDULE 13GOpen filing 0001493152-26-015369 Dispute this row
David Paolella Common Stock, $0.001 par value per share5.3391,862.0003/30/2026 Filed 2026-04-06SCHEDULE 13GOpen filing 0001493152-26-015369 Dispute this row
TANG CAPITAL MANAGEMENT, LLC Common Stock, par value $0.001 per share9.0664,314.0003/30/2026 Filed 2026-04-01SCHEDULE 13D/AAmendment 1Open filing 0001214659-26-004166 Dispute this row
KEVIN TANG Common Stock, par value $0.001 per share9.0664,314.0003/30/2026 Filed 2026-04-01SCHEDULE 13D/AAmendment 1Open filing 0001214659-26-004166 Dispute this row
TANG CAPITAL PARTNERS, LP Common Stock, par value $0.001 per share00.0003/30/2026 Filed 2026-04-01SCHEDULE 13D/AAmendment 1Open filing 0001214659-26-004166 Dispute this row
TANG CAPITAL PARTNERS INTERNATIONAL, LP Common Stock, par value $0.001 per share3.7272,272.0003/30/2026 Filed 2026-04-01SCHEDULE 13D/AAmendment 1Open filing 0001214659-26-004166 Dispute this row
TANG CAPITAL PARTNERS III, INC Common Stock, par value $0.001 per share5.3392,042.0003/30/2026 Filed 2026-04-01SCHEDULE 13D/AAmendment 1Open filing 0001214659-26-004166 Dispute this row
TANG CAPITAL PARTNERS IV, INC Common Stock, par value $0.001 per share00.0003/30/2026 Filed 2026-04-01SCHEDULE 13D/AAmendment 1Open filing 0001214659-26-004166 Dispute this row
CONCENTRA BIOSCIENCES, LLC Common Stock, par value $0.001 per share00.0003/30/2026 Filed 2026-04-01SCHEDULE 13D/AAmendment 1Open filing 0001214659-26-004166 Dispute this row
Stonepine Capital Management, LLC Common Stock2.1156,179.0012/31/2025 Filed 2026-02-13SCHEDULE 13G/AAmendment 1Open filing 0000935836-26-000091 Dispute this row
Stonepine Capital, L.P. Common Stock2.1156,179.0012/31/2025 Filed 2026-02-13SCHEDULE 13G/AAmendment 1Open filing 0000935836-26-000091 Dispute this row
Stonepine GP, LLC Common Stock2.1156,179.0012/31/2025 Filed 2026-02-13SCHEDULE 13G/AAmendment 1Open filing 0000935836-26-000091 Dispute this row
Jon M. Plexico Common Stock2.1156,179.0012/31/2025 Filed 2026-02-13SCHEDULE 13G/AAmendment 1Open filing 0000935836-26-000091 Dispute this row
BML Investment Partners, L.P. Common Stock, $0.001 par value9.8720,78712/31/2025 Filed 2026-02-09SCHEDULE 13G/AAmendment 2Open filing 0001373604-26-000018 Dispute this row
Avidity Partners Management LP Common Stock, par value $0.001 per share0.00.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 4Open filing 0000919574-25-006912 Dispute this row
Avidity Partners Management (GP) LLC Common Stock, par value $0.001 per share0.00.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 4Open filing 0000919574-25-006912 Dispute this row
Avidity Capital Partners Fund (GP) LP Common Stock, par value $0.001 per share0.00.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 4Open filing 0000919574-25-006912 Dispute this row
Avidity Capital Partners (GP) LLC Common Stock, par value $0.001 per share0.00.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 4Open filing 0000919574-25-006912 Dispute this row
Avidity Master Fund LP Common Stock, par value $0.001 per share0.00.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 4Open filing 0000919574-25-006912 Dispute this row
Michael Gregory Common Stock, par value $0.001 per share0.00.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 4Open filing 0000919574-25-006912 Dispute this row
Stonepine Capital Management, LLC Common Stock5.2377,240.0009/02/2025 Filed 2025-09-08SCHEDULE 13GOpen filing 0000935836-25-000592 Dispute this row
Stonepine Capital, L.P. Common Stock5.2377,240.0009/02/2025 Filed 2025-09-08SCHEDULE 13GOpen filing 0000935836-25-000592 Dispute this row
Stonepine GP, LLC Common Stock5.2377,240.0009/02/2025 Filed 2025-09-08SCHEDULE 13GOpen filing 0000935836-25-000592 Dispute this row
Jon M. Plexico Common Stock5.2377,240.0009/02/2025 Filed 2025-09-08SCHEDULE 13GOpen filing 0000935836-25-000592 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,762,359 filings read, dated 2004-06-14 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
2015178,741
2016222,642
2017222,009
2018223,345
2019216,482
2020226,343
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026263,828

Filings made before the SEC required XML are listed, not extracted.

Back to Kezar Life Sciences, Inc.